1887

Abstract

We have previously shown that immunization with solid matrix-antigen-antibody (SMAA) complexes induces both vigorous humoral and cell-mediated immune responses and have suggested that this method of vaccination may be developed for use in humans, and potentially as a vaccine against AIDS. Here we demonstrate that a small oligopeptide can act as a tag for the construction of SMAA complexes using a tag-specific monoclonal antibody and tag-linked antigens. We show that a 14-amino acid oligopeptide, present in the phospho (P) and V proteins of simian virus 5 (SV5), retains its antigenicity when attached to the C terminus of three ‘foreign’ proteins [p27 and gp110 of simian immunodeficiency virus (SIV) and glutathione -transferase] such that these proteins can be incorporated into SMAA complexes using a monoclonal antibody (MAb) that was originally raised against the native SV5 P and V proteins. Mice were immunized with SMAA complexes containing recombinant p27-TAG and MAbs have been isolated that recognized native SIV p27. The significance of these results in terms of the development of SMAA complexes as human vaccines is discussed.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-73-3-653
1992-03-01
2021-08-05
Loading full text...

Full text loading...

/deliver/fulltext/jgv/73/3/JV0730030653.html?itemId=/content/journal/jgv/10.1099/0022-1317-73-3-653&mimeType=html&fmt=ahah

References

  1. Birnboim H. C., Doly J. 1979; A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Research 7:1513–1523
    [Google Scholar]
  2. Boulot G., Eisele J.-L., Bentley G. A., Bhat T. N., Ward E. S., Winter G., Poliak R. J. 1990; Crystallization and preliminary X-ray diffraction study of the bacterially expressed Fv from the monoclonal and anti-lysozyme antibody DI.3 and of its complex with antigen, lysozyme. Journal of Molecular Biology 213:617–619
    [Google Scholar]
  3. Ferns R. B., Tedder R. S., Weiss R. A. 1987; Characterization of monoclonal antibodies against the human immunodeficiency virus (HIV) gag products and their use in monitoring HIV isolate variation. Journal of General Virology 68:1543–1551
    [Google Scholar]
  4. Hanke T., Graham F. L., Lulitanond V., Johnson D. 1990; Herpes simplex IgG Fc receptors induced using recombinant adenovirus vectors expressing glycoproteins E and I. Virology 177:437–444
    [Google Scholar]
  5. Kessler S. W. 1975; Rapid isolation of antigens from cells with a staphylococcal Protein-A antibody adsorbent: parameters of the interaction of antibody-antigen complexes with Protein A. Journal of Immunology 115:1617–1624
    [Google Scholar]
  6. Kornfeld H., Riedel N., Viglianti G. A., Hirsch V., Mullins J. I. 1987; Cloning of HTLV-4 and its relation to simian and human immunodeficiency viruses. Nature, London 326:610–613
    [Google Scholar]
  7. Kushner S. R. 1978; An improved method for transformation of Escherichia coli with ColEl-derived plasmids. In Genetic Engineering p 17 Edited by Boyer H. B., Nicosia S. Amsterdam: Elsevier;
    [Google Scholar]
  8. Maniatis T., Fritsch E. F., Sambrook J. 1982 Molecular Cloning: A Laboratory Manual New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
  9. Page M. J., Sydenham M. A. 1991; High level expression of the humanized monoclonal antibody CAMPATH-1H in Chinese hamster ovary cells. Bio/Technology 9:64–68
    [Google Scholar]
  10. Randall R. E. 1989; Solid matrix-antibody-antigen (SMAA) complexes for constructing multivalent subunit vaccines. Immunology Today 10:336–339
    [Google Scholar]
  11. Randall R. E., Souberbielle B. E. 1990; Presentation of virus antigens for the induction of protective immunity. In Control of Virus Diseases pp 21–51 Edited by Dimmock N. J., Griffiths P. D., Madeley C. R. Cambridge: Cambridge University Press;
    [Google Scholar]
  12. Randall R. E., Young D. F. 1988; Humoral and cytotoxic T cell immune responses to internal and external structural proteins of simian virus 5 induced by immunization with solid matrix–antibody–antigen complexes. Journal of General Virology 69:2505–2516
    [Google Scholar]
  13. Randall R. E., Young D. F. 1989; Immunization against multiple viruses using solid matrix–antibody–antigen complexes. Journal of Virology 63:1808–1810
    [Google Scholar]
  14. Randall R. E., Young D. F. 1991; Solid matrix–antibody–antigen complexes induce antigen-specific CD8+ cells that clear a persistent paramyxovirus infection. Journal of Virology 65:719–726
    [Google Scholar]
  15. Randall R. E., Young D. F., Goswami K. K. A., Russell W. C. 1987; Isolation and characterization of monoclonal antibodies to simian virus 5 and their use in revealing antigenic differences between human, canine and simian isolates. Journal of General Virology 68:2769–2780
    [Google Scholar]
  16. Randall R. E., Young D. F., Southern J. A. 1988; Immunization with solid matrix–antibody–antigen complexes containing surface or internal virus structural proteins protects mice from infection with the paramyxovirus, simian virus 5. Journal of General Virology 69:2517–2526
    [Google Scholar]
  17. Reichmann L., Clark M., Waldmann H., Winter G. 1988; Reshaping human antibodies for therapy. Nature, London 332:323–327
    [Google Scholar]
  18. Skerra A., Pfitzinger I., Pluckthun A. 1991; The functional expression of antibody Fv fragments in Escherichia coli: improved vectors and generally applicable purification technique. Bio/Technology 9:273–278
    [Google Scholar]
  19. Smith D. B., Johnson K. S. 1988; Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67:31–40
    [Google Scholar]
  20. Southern J. A., Young D. F., Heaney F. C., Baumgärtner W. K., Randall R. E. 1991; Identification of an epitope on the P and V proteins of simian virus 5 that distinguishes between two isolates with different biological characteristics. Journal of General Virology 72:1551–1557
    [Google Scholar]
  21. Tempest P. R., Bremner P., Lambert M., Taylor G., Furze J. M., Carr F. J., Harris W. J. 1991; Reshaping a human monoclonal antibody to inhibit human respiratory syncytial virus infection in vivo . Bio/Technology 9:266–271
    [Google Scholar]
  22. Verhoeyen M., Milstein C., Winter G. 1988; human antibodies: grafting an antilysozyme activity. Science 239:1534–1536
    [Google Scholar]
  23. Vlak J. M., Keus R. J. A. 1990; Baculovirus expression vector system for production of viral vaccines. In Viral Vaccines pp 94–118 Edited by Mizrahi A. New York: Wiley-Liss;
    [Google Scholar]
  24. Winter G., Milstein C. 1991; Man-made antibodies. Nature, London 349293–299
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-73-3-653
Loading
/content/journal/jgv/10.1099/0022-1317-73-3-653
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error